Cargando…
The need to manage the risk of thromboembolism in COVID-19 patients
COVID-19 first appeared in Wuhan, Hubei Province, China, in December 2019. Thought to be of zoonotic origin, it has been named SARS-CoV-2 (COVID-19) and has spread rapidly. As of April 20, 2020, there have been >2.4 million cases recorded worldwide. The inflammatory process, cytokine storm, and l...
Autores principales: | Khan, Inayat Hussain, Savarimuthu, Sugeevan, Leung, Marco Shiu Tsun, Harky, Amer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the Society for Vascular Surgery. Published by Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7224653/ https://www.ncbi.nlm.nih.gov/pubmed/32417304 http://dx.doi.org/10.1016/j.jvs.2020.05.015 |
Ejemplares similares
-
Early experience with arterial thromboembolic complications in patients with COVID-19
por: Indes, Jeffrey E., et al.
Publicado: (2021) -
The role of ECMO in COVID‐19: Can it provide rescue therapy in those who are critically ill?
por: Savarimuthu, Sugeevan, et al.
Publicado: (2020) -
Risk and Management of Venous Thromboembolism in Patients with COVID-19
por: Skeik, Nedaa, et al.
Publicado: (2021) -
COVID era “essential surgery” dialysis access management considerations
por: Kirksey, Lee, et al.
Publicado: (2020) -
Arterial thromboembolic complications in COVID‐19 in low‐risk patients despite prophylaxis
por: Griffin, Daniel O., et al.
Publicado: (2020)